General MedicationsINTRAVENOUSStandard
XIFYRM
MELOXICAM
Standard Dose
30MG/ML (30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview XIFYRM is listed in Drugs@FDA under application 218395 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MELOXICAM Form and strength SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) Sponsor AZURITY Submission history Latest submission status date: 2025-06-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview XIFYRM is listed in Drugs@FDA under application 218395 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MELOXICAM Form and strength SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) Sponsor AZURITY Submission history Latest submission status date: 2025-06-05 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.